Viewing nowCombinationTwinbeta Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 201702695 · Approved 2017.05.30 · Insurance code 694001380
Treatment of essential hypertension not controlled by monotherapy
This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with telmisartan or amlodipine monotherapy. It helps to reduce the risk of cardiovascular complications by effectively lowering blood pressure. It will be prescribed in an appropriate dosage according to the patient's condition and contributes to maintaining health by better controlling blood pressure.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration (only for this medicine 40/5 mg and 80/10 mg). ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (Refer to section “3. Patients who should be administered this medicine with caution.”) In patients 75 years and older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
◦ Children: Administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication should not be used by pregnant women or women who may become pregnant, as it can cause serious harm to the fetus, particularly in the second and third trimesters. If a pregnant woman is found to be taking this medication, it should be discontinued immediately, and if necessary, replaced with another safe medication. This drug should not be administered to patients with known allergies to certain ingredients, severely impaired liver function, severe hypotension, or severe cardiovascular diseases. Furthermore, caution is required in patients with impaired renal function or some diabetic patients due to the potential risks of co-administration with certain other medications. Patients with weak liver and kidney function, gastrointestinal disorders, elderly patients, etc., should be closely monitored and administered carefully while using this medication. During treatment, side effects such as dizziness, edema, hypotension, etc., may occur, and any abnormal symptoms should be immediately discussed with a healthcare provider. Symptoms of sudden blood pressure drop may occur, thus if hypotension symptoms present, the patient should be laid down and may require intravenous fluid therapy if necessary. This medication may interact with other drugs, so it is essential to inform your doctor or pharmacist if you are taking other medications, especially potassium-containing supplements or certain cardiac medications. Caution should be exercised as dizziness or drowsiness may be experienced when driving or operating hazardous machinery. The safety and efficacy for children have not been sufficiently established; therefore, it is not recommended. In the elderly, dosage adjustment may be needed. Overdose can pose risks such as hypotension, arrhythmias, or acute renal failure, therefore immediate medical attention should be sought. This medication should be kept out of the reach of children, and transferring it to another container is not recommended as it may affect the quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it is recommended to store the medication at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its efficacy and prevent degradation.
Biconvex oval double tablet in white and light blue color
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.